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The structure of the antimicrobial 
human cathelicidin LL‑37 shows 
oligomerization and channel 
formation in the presence 
of membrane mimics
Enea Sancho‑Vaello1,7, David Gil‑Carton2, Patrice François 3, Eve‑Julie Bonetti3, 
Mohamed Kreir4,8, Karunakar Reddy Pothula 5, Ulrich Kleinekathöfer 5 & Kornelius Zeth6*
The human cathelicidin LL‑37 serves a critical role in the innate immune system defending bacterial 
infections. LL‑37 can interact with molecules of the cell wall and perforate cytoplasmic membranes 
resulting in bacterial cell death. To test the interactions of LL‑37 and bacterial cell wall components 
we crystallized LL‑37 in the presence of detergents and obtained the structure of a narrow tetrameric 
channel with a strongly charged core. The formation of a tetramer was further studied by cross‑
linking in the presence of detergents and lipids. Using planar lipid membranes a small but defined 
conductivity of this channel could be demonstrated. Molecular dynamic simulations underline the 
stability of this channel in membranes and demonstrate pathways for the passage of water molecules. 
Time lapse studies of E. coli cells treated with LL‑37 show membrane discontinuities in the outer 
membrane followed by cell wall damage and cell death. Collectively, our results open a venue to the 
understanding of a novel AMP killing mechanism and allows the rational design of LL‑37 derivatives 
with enhanced bactericidal activity.
The increase in antibiotic resistance is one of the biggest health challenges our society is currently  facing1. As 
a consequence, the discovery of new bactericidal drug candidates from any source including antimicrobial 
peptides (AMPs) is  urgent2–4. According to recent studies antimicrobial peptides have the potential to become 
lead structures due to their ability to effectively eradicate pathogenic bacteria and  biofilms5–7. However, in spite 
of the large number of AMPs only a minor fraction was introduced into clinical studies and none of those went 
into the pharmaceutical  market8. This failure converting natural AMPs to drug candidates can be traced to our 
lack of understanding the mechanisms whereby they target and kill bacterial cells, hence the rational basis for a 
design of peptides with tailored properties is impeded. Therefore more AMP structures, ideally in complex with 
their cellular targets, are needed to track their pathways and define interfaces of AMP/target-complexes. Using 
this information, we will be able to specifically enhance their properties by peptide  design9.
AMPs in mammals form part of the innate immune  response4. Their activity includes functions in micro-
bial killing, inflammation, angiogenesis and wound  healing4,10. According to recent studies the physiological 
concentrations of some AMPs may be sufficient to densely cover the bacterial surface and initiate bacterial cell 
 death11. Most AMPs typically carry a significant surplus of surface exposed positive charges and hence, they 
can initially interact with the negatively charged cell surface exposed lipopolysaccharides (LPS) or lipoteichoic 
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acid (LTA) molecules of Gram-negative and -positive bacteria eventually extracting these molecules from the 
cell wall before entering the  cell12–15. Further steps of action depend on the peptide under investigation and the 
bacterial cell type. It is assumed that amphipathic and α-helical AMPs can perforate the cytoplasmic membrane, 
a structure also considered to be the ‘Achilles heel of bacterial cells’, resulting in the breakdown of the trans-
membrane  potential3. Due to the structural variability of AMPs and their unspecific mode of action various 
interaction partners (either specific or unspecific) are known at the cell wall, the periplasmic space and inside 
the bacterial  cytoplasm16–20. Within the cytoplasm some AMPs can target protein, DNA or RNA complexes such 
as the  ribosome21,22. As an example, the complex of the ribosome-associated Onc112 peptide and the Thermus 
thermophilus 70S ribosome has been discovered and provided the first structural information of an AMP at high 
resolution with its specific  target21,22.
One of the first steps of the cellular targeting may include binding and oligomerization of AMPs at cell wall 
constituents (LPS, LTA, lipid membranes). Oligomerization and fiber formation of AMPs has recently been 
shown to occur on lipid vesicles and can also be initiated by detergents, a mechanism possibly important for AMP 
activation and  killing23,24. One of the first studies describing fiber formation via end-to-end alignment was based 
on the fluorescently labelled cationic peptide LAH4 when attached to  membranes25. In addition, supramolecular 
structures based on their higher oligomeric state in crystal lattices were deduced from the BTD-2 antimicrobial 
peptide or the membrane-disruptive phenol-soluble modulin alpha 3 (PSMα3)26–28. BTD-2 peptides organize 
in a fibril-like state within the crystal lattice similar to fibrils of PSMα3, both of which appear to form amyloid-
like states via zipper motifs providing structural evidence linking antimicrobial and amyloid  peptides27. LL-37 
has also been shown to form fibres when incubated with lipid vesicles using electron  microscopy23. In our own 
study we showed the supramolecular formation of LL-37 fibers in crystal lattices mediated in an head-to-tail 
arrangement of dimers. We confirmed these fibers by electron microscopy using gold-labelled peptides incubated 
with lipid  vesicles24.
Membrane perturbation is considered to be another, possibly subsequent mechanistic step during the course 
of cellular targeting. Three simple mechanistic models depict this interaction of α-helical amphipathic AMPs 
with uniform bilayers. However, these models are insufficient in their ability to explain the biological context 
of AMP-membrane interactions under in vivo conditions due to their  simplicity9,12,29,30. The models describe 
interactions with artificial lipid membranes on the basis of moderate to strong hydrophobic and hydrophilic 
attraction within peptide-lipid complexes, initiating membrane disturbance. The barrel-stave model emphasizes 
the assembly of peptides leading to oligomeric transmembrane channels which expose their hydrophobic surfaces 
towards artificial  membranes31. The toroidal model describes the pore formation by AMPs strongly interact-
ing with lipid head groups and alkyl chains but assuming only weak peptide-peptide  interactions32,33. Finally, 
the carpet model explains the disintegration of the artificial membrane in a detergent-like manner, with AMPs 
encapsulating lipid  micelles34.
The barrel stave model which describes a rigid membrane-disrupting peptide complex is possibly the most 
detailed data-based mechanistic model. However, up until now, there is only one AMP structure of Dermcidin 
(DCD) published by our laboratory available which demonstrates a defined transmembrane channel validating 
the barrel stave model for this  peptide35. DCD shows an unusual strongly charged channel of 8 nm length exhib-
iting discrete conductance steps in planar  membranes9,35,36. Although the structure was solved in the absence 
of detergents and lipids, the channel clearly shows the archetypical features of six membrane-spanning helices 
arranged in pairs of anti-parallel dimers with a hydrophobic surface facing the putative membrane. Another 
channel-forming AMP is alamethicin, a well-studied peptide that has served as a paradigm for voltage-gated 
channels. The peptide was probed by Woolley to be a  dimer37 but also a hexameric channel structure was 
 proposed38,39. The hexameric state of alamethicin is supported by another study on using electrochemical scan-
ning tunnelling microscopy (EC-STM) which shows hexameric pores formed in a matrix of  phospholipids40.
Human cathelicidin comprises the cathelin precursor domain and LL-37 as C-terminal  extension41,42. LL-37 is 
activated through proteolytic cleavage as a mature  peptide43 comprising 37 amino acids including two N-terminal 
leucines and a net positive charge of + 6. This peptide was extensively studied by biochemical, biophysical and 
structural  methods10. Early studies by NMR on LL-37 dissolved in a buffer comprising the denaturing SDS 
showed a monomeric and strongly bent helical  structure44. By contrast, recent crystallographic studies dem-
onstrated an anti-parallel dimer of peptides in the absence of  detergents24. This dimer undergoes significant 
structural changes in the N- and C-terminus after interacting with detergents such as dodecylphosphocholine 
(DPC) or lauryldimethylamine oxide (LDAO), and defined and stable detergent interaction sites were obtained 
in high resolution structures likely resembling lipid binding sites in vivo. These sites are also observed by NMR of 
LL-37 in the presence of DPC proving the same interacting aromatic residues mapped on a tripartite  structure45.
The mechanism by which LL-37 interacts with the bacterial cell wall has not been investigated in much detail. 
Consequently, our primary aim was to understand how LL-37 interacts with molecules of the bacterial cell wall 
and to characterize these interactions based on secondary, tertiary and quaternary structures, respectively. Here 
we report crystallographic investigations which reveal the tetrameric structure of LL-37 crystallized in the pres-
ence of DPC. The existence of this oligomer in lipid bilayers was proven by cross-linking and circular dichroism 
(CD). Molecular dynamic studies of the tetramer embedded in a bacterial membrane system proved physical 
stability and flow of water molecules through the channel was monitored. To investigate the function of this 
channel structure we used planar lipid membranes and determined a small but defined conductivity. Finally, 
in vivo studies using electron microsopy of E. coli cells incubated with LL-37 show discontinuities in the outer 
and inner membrane followed by the breakdown of the membrane system. Together with a previous paper on 
the fiber formation of LL-37 our data form the basis to construct a new mechanism of LL-37 targeting bacterial 
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Results
LL‑37 forms a narrow tetrameric channel structure in the presence of DPC. We crystallized 
LL-37 in the presence of detergents to achieve new detergent-induced structural states of LL-37 states. Previously 
we obtained peptide-detergent complexes comprising structurally ordered detergents attached to hydrophobic 
surface areas (structure termed LL-37DPC-2 in the following). In our new crystallization attempts of LL-37 in 1% 
DPC crystals were formed in the presence of 70% MPD. The structure was solved by molecular replacement 
using the monomer structure of LL-37DPC-2 as a search model. Two antiparallel monomers in the asymmetric 
unit are crystallographically related to a second dimer, together building a narrow tetrameric 4 nm long channel 
structure (termed LL-37DPC-4; see Figs. 1A, S1D, S2). Notably, this channel does not follow an exact twofold sym-
metry along the crystallographic channel axis (see Figs. 1, S1D, S2). Disordered residues are observed at both 
termini resulting in an ordered channel core structure only comprising residues Phe6 to Asn30 (see Figs. 1, S1). 
Although narrow, the channel shows a continuous and charged inner cavity between the terminal pores with a 
constriction at the centre (see Fig. S2B). Due to this asymmetric arrangement three different peptide interfaces 
(IF1, IF2 and IF3) are formed, two of which (IF1) are identical dimer interfaces stabilized by the hydrophobic 
residues Ile13, Phe17, Ile20, Ile24, Phe27 and Leu31 (interface area 445 Å2—see Fig. 1A). IF1 is further stabilized 
by two salt bridges involving residues Glu16 and Arg23 (see Fig. S2C). The IF2 is stabilized by four hydrophilic 
residue pairs Lys15/Asn30 and Arg19/Asp26 (contact area 344 Å2; see Fig. S2C). In analogy to IF2 also the small-
est interface IF3 is formed by four salt bridges including residues Glu16/Arg23 and Arg19/Asp26 (contact area 
339 Å2; see Figs. 1A, S2C). In the interior of the channel-like structure a chloride ion is trapped by two Arg23 
residues from adjacent monomers and further coordinated by two water molecules (see Figs. 1B, S1, S2C). The 
interior of the channel displays a dense network of H-bond interactions and 15 coordinated water molecules 
while water molecules surrounding the tetrameric channel are essentially absent (see Fig. S1D). The charged 
channel core, with a surplus of positive charges and 3 nm in length, is delimited by two aromatic girdles (formed 
by eight Phe residues, four Phe17 and four Phe27 residues) arranged at a distance of ~ 2 nm pointing towards the 
putative membrane environment, respectively (see Fig. 1B).
We analyzed all crystallographically determined LL-37 structures of this and a previous paper to identify 
structural changes in response to the presence of detergents as well as the monomer and dimer conformations 
(see Fig. S3)24. Firstly, the superposition of the two peptides in the asymmetric unit of LL-37DPC-4 proves them 
to be identical with a r.m.s.d of 0.4 Å (for CA atoms of residues 6–30). Interestingly, the dimer architecture of 
this structure is very different to the previously reported structures of LL-37DPC-2 and the structure crystallized 
in the absence of detergents LL-3724 (see Fig. S3). The two monomers of the LL-37DPC-4 asymmetric unit need to 
be shifted by about five turns relative to each other to form the LL-37DPC-2 structure. Secondly, the r.m.s.d of the 
monomer in LL-37DPC-4 relative to LL-37 structure (crystallized without detergents) is 1.2 Å while the deviation 
to the LL-37DPC-2 structure monomer is only 0.4 Å, indicating a better structural fit between the detergent induced 
structures. In summary, the tetrameric structure of LL-37 comprising antiparallel peptide monomers is formed 
on the basis of three different hydrophobic or hydrophilic interfaces, respectively.
Studies on the secondary structure and oligomerization state of LL‑37 upon interaction with 
detergent and lipids confirm the existence of a tetramer. In order to show that the crystallized state 
induced by detergents mimics a structural state found in lipid membranes, we monitored secondary structure 
Figure 1.  The structure of LL-37DPC-4 provides insights into the putative transmembrane channel architecture. 
(A) LL-37DPC-4 in surface representation and analysis of IF1-IF3 viewing the side dominated by hydrophobic 
residues emphasized in green and marked by sequence numbers. The IF1 is formed by hydrophobic residues, 
while IF2 and IF3 are formed by a mix of polar and charged residues (marked magenta, red and blue surface). 
Residues involved in the maintenance of each interface are marked by numbers. (B) Aromatic girdles in the 
tetrameric arrangement indicate the potential for membrane integration architecture. Two phenylalanines of 
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and oligomeric state changes in response to detergents and lipids. First, LL-37/DPC mixtures were employed 
in physiological buffer at increasing detergent concentrations with a starting concentration below the critical 
micelle concentration (CMC) (100 mM NaCl, 5 mM phosphate, pH 7; 0.14 mM—5.7 mM, CMC: 1.5 mM). 
The spectrum obtained for LL-37 alone displays high ellipticity values at 208 and 222 nm, typical for α-helical 
structures. Because LL-37 is a well folded peptide in a buffer containing 100 mM NaCl, the intensity of the spec-
trum changed only marginally in response to increasing DPC concentrations (see Fig. S4). Cross-linking in the 
presence of 0.2–1% DPC using glutaraldehyde and BS3 as a cross-linker yielded monomeric-tetrameric bands at 
decreasing intensity (data not shown).
In order to prove the existence of the LL-37 tetramer in membrane-like environments, we performed studies 
on the secondary structure and oligomerization behavior in the presence of lipids. Since phosphatidylethan-
olamine (PE) and phosphatidylglycerol (PG) are the main lipid components of the inner bacterial membrane a 
mixture of PE:PG (3:1) was employed for these  experiments46. To compare the effect of another non-bacterial 
lipid, we chose phosphatidylcholine (PC) which is the major component of eukaryotic cell membranes and has 
the same head group as  DPC47. At high ratios of LL-37:PE/PG, the ellipticity increased significantly while the 
secondary structure remained essentially the same for all LL-37:PC ratios, resembling the results from DPC meas-
urements (see Fig. 2A,B). In the presence of all the tested lipids, the typical α-helix spectrum with the minimum 
at 208 and 222 nm confirmed the expected folding for the peptide. In order to characterize the oligomerization 
state of LL-37 under the same conditions chosen for CD, we performed cross-linking experiments using BS3 as a 
cross-linker. In the absence of lipids and BS3, a dimer of LL-37 (at ~ 9 kD) was observed. After adding BS3 alone, 
a strong band corresponding to tetramers (at ~ 15 kD) was observed with a weak band in between potentially 
representing trimers. In the presence of BS3 and lipids, the most prominent band corresponds to the tetramer 
and a weak band corresponding to a hexamer at ~ 25 kD is visible at higher LL-37:lipid ratios (see Fig. 2C). Trimer 
and tetramer bands only disappeared at a high PE:PG ratio of 1:5 but remained at the same ratio for the LL-37:PC 
mixture. These experiments support the existence and stabilization of a LL-37 tetramer in the presence of both 
bacterial and eukaryotic membrane lipids particularly at higher lipid:peptide ratios.
Based on the crystal structures we designed two points mutants (E16A and R23A) to decipher the influence of 
single residues onto the structure conformation, oligomerization and activity of LL-37. The mutant residues are 
the main interacting residues at the dimer interface. Here, Glu16 forms a salt bridge with Lys12 and a hydrogen 
bond with Ser9 in the LL-37 structure in the dimeric LL-37 structure (PDB:5NNM). In the LL-37DPC-2 structure 
(PDB:5NNT) crystallized in the presence of DPC, Glu16 interacts with Ser9 but not Lys12. Arg23 has strong 
implications in the formation of the fibrils as introduced in the paper by Sancho-Vaello et al. and interacts with 
the head group of the detergents DPC and LDAO used for crystallization. In LL-37DPC-4 the Glu16 residue inter-
acts with three positively charged residues Lys12, Arg19 and Arg23 in the first peptide chain as well as Lys12 and 
Arg23 but not Arg19 in the second. In CD, only E16A exhibited a decrease in ellipticity, which was recovered 
after addition of detergent (see Fig. S5A). The pattern of bands in the cross-linking using BS3 was altered for 
both mutants. Whereas E16A does not show any evidence of oligomerization and seemed to have precipitated 
Figure 2.  Analysis of the folding and oligomerization states of LL-37 in the presence of PE:PG (3:1) or PC by 
circular dichroism and cross-linking. (A) Circular dichroism at different LL-37/(PE:PG) ratios. Only at higher 
LL-37:(PE:PG) ratios (see blue and black lines for 1:5 and 1:10 ratios, respectively) did the ellipticity relative to 
the spectrum in the absence of lipids increase. (B) Circular dichroism of LL-37/PC mixtures. At the smallest 
LL-37:PC ratio (see red line for 1:0.1 ratio) a small unfolding of LL-37 is suggested. (C) Cross-linking of LL-37 
in the presence of the mixture PE:PG (3:1) or PC using BS3 as a cross-linker. Left gel: Lane 1: Molecular weight 
marker; Lanes 2–3: LL-37 in the absence and presence of BS3; Lanes 4–8: LL-37/(PE:PG) mixture at 1:0.1, 1:0.3, 
1:1, 1:2 and 1:5 ratios; Lane 9: same as lane 8 but lacking BS3; Lanes 10–15: LL-37/PC mixtures at 1:0.1, 1:0.3, 
1:1, 1:2, 1:5 and 1:10 ratios. Right gel: Lane 1: Molecular weight marker; Lane 2: LL-37/(PE:PG) mixtures at 1:10. 
The gels were silver stained.
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under the chosen conditions (reproducible loss of signal in the gel), R23A showed oligomerization but different 
to the one exhibited by the wild type peptide (see Fig. S5B).
LL‑37 forms ohmic conductance pores in artificial planar membranes. To obtain additional func-
tional evidence for the formation of a channel and its activity in artificial membranes we determined conduc-
tivity in planar lipid bilayers (the control line was recorded before any addition of peptide, see Fig. 3A). Mem-
branes containing 1,2-diphytanoyl-sn-glycero-3-phosphocholine (DPhPC) and cholesterol were prepared and 
LL-37 was applied in concentrations similar to those used in antimicrobial assays. The voltage-conductivity 
relationship of the channel was determined to be linear between -200 and + 200 mV following an ohmic behavior 
(Fig. 3E). Transmembrane current steps at 200 mM KCl were observed from which three main conductances of 
Closed state (C) to O1 = 13.3 pS, O1 to O2 = 12.8 pS and O2 to O3 = 12.96 pS could be distinguished (see Fig. 3B–
D). The conductances were calculated for the different levels of openings using a Gaussian fit for all the points in 
the  histogram48. The major conductance step was determined to be O2 with 900 counted states in comparison to 
O1 and O3 with approximately 100 signals counted (see Fig. 3D). These mean openings allowed us to calculate 
the average channel conductance of 13 pS at a voltage of 100 mV with a mean open lifetime that was estimated to 
be τ = 1.8 ms and an open probability PO of 0.71 (see Fig. S6). In summary, the planar lipid membrane measure-
ments confirm the formation of a LL-37 peptide channel with a defined but small conductance.
Molecular dynamic simulations demonstrate channel stability in POPE/POPG membranes. In 
order to examine if the tetrameric structure was energetically stable when embedded in artificial membranes, 
MD simulations of a peptide-membrane system were executed. Unbiased simulations of the channel in a phos-
phatidyl ethanolamine/phosphatidyl glycerol (POPE/POPG, 3:1) bilayer were performed (see Fig.  4A). As 
shown in Fig.  4B, the LL-37DPC-4 structure embedded in membranes does not vary considerably during the 
simulations. The various MD states show r.m.s.d values of 2.5 Å to 3 Å including all Cα-atoms relative to the 
crystals structure (see Fig. S7A). To further examine the structural stability we also monitored the interhelical 
distances to investigate the packing arrangement relative to the crystal structure. The interhelical distances of 
adjacent helix pairs remained largely undisturbed for the time of simulation indicating no significant changes, 
and leading to the conclusion that the structure is inherently stable under the conditions chosen (see Fig. S7B).
To determine the in-membrane movement of LL-37, including the tilt angle between the channel axis and the 
bilayer normal, we performed 200 ns simulations towards equilibrium states. These states normally reflect the 
peptide-membrane architecture at an energetic minimum after matching hydrophobic and hydrophilic properties 
of peptides and lipid chemistry. In two independent simulations, the channel was found to be tilted by about 20 
degrees with respect to the membrane (see Fig. 4C). The energetic minimum matches the hydrophobic length 
of the channel with the membrane thickness and positively charged residues on the external interface with 
negatively charged POPG residues in the membrane.
When water molecules were added to the system they rapidly occupied positions in the interior of the asym-
metric peptide channel during unbiased simulations and their localization is shown in Fig. 4D. The water distri-
bution in the different slices along the channel axis is shown in Fig. 4E. Furthermore, we noticed a preferential 
movement of waters along IF2 and IF3 which is in agreement with the water distribution in the crystal structure 
(Fig. S8 for the water distribution in the channel). Furthermore, we tested the stability of the tetramer chan-
nel in single component bilayers (POPC, POPE and POPG) and found that the structure showed similar rmsd 
changes (Fig. S7C) and tilt angles (Fig. S7D) as that of the structure in a multiple component POPE/POPG bilayer. 
Consistent with the fact that LL-37 has a higher selectivity for prokaryotic than for eukaryotic membranes, in 
simulations LL-37 shows fewer hydrogen bond interactions with the POPC membrane than with the POPE and 
POPG membranes wherein stable protein-lipid complexes are formed (Fig. 4F). Collectively, we can demonstrate 
that LL-37 is stable during all MD simulations in POPE and POPG bilayers and shows translocation of water 
molecules along the groove-like structure.
Antimicrobial activity of wildtype LL‑37 and mutants against Staphylococcus aureus, Pseu-
domonas syringae, Streptococcus pyogenes and Escherichia coli. The structure-based mutants 
of LL-37 were also used to estimate their activity against Gram-positive and -negative bacteria. As previously 
explained, we designed the E16A and R23A mutant peptides to investigate their implications in peptide interac-
tions. We speculated that oligomerization was important for activity and mutants may reveal a different activ-
ity profile. Using the wildtype peptide and the bacterial strains E. coli K12 (6.25 µg/ml; 1.4 μM), S. aureus JE2 
(25 µg/ml; 5.6 μM), P. syringae (6.25 µg/ml; 1.4 μM) and S. pyogenes (3.25 µg/ml; 0.73 μM) we found low minimal 
inhibitory concentration (MIC) values in the range of 3.25 to 25 µg/ml. Both mutants were essentially inactive 
against all four strains tested except R23A that maintained activity against S. pyogenes (6.25 µg/ml) (see Table SI). 
In summary, the structural analysis of LL-37 provided deep insights into the mode of oligomerization via inter-
faces which can be altered by mutation leading to altered activity.
An additive inhibitory effect of LL-37 was observed for S. aureus on plates containing daptomycin, an antibi-
otic used for severe methicillin-resistant S. aureus (MRSA) infections, and known to interact with bacterial lipid 
 membranes49. Correlation of cell membrane lipid profiles with daptomycin resistance in methicillin-resistant S. 
aureus has been  reported49. The presence of LL-37 in the medium increased the susceptibility of S. aureus against 
daptomycin significantly from 0.094 to 0.020 mg/ml (see Fig. S9). No additive inhibitory effects on S. aureus 
cultures containing the cell wall targeting component ceftobiprole or tigecycline antibiotics were found. Note 
that our strain from the CC8 complex suggests that this additive effect is not limited to strains showing USA600 
genetic  background50. In other Gram-positives such as Enterococcus51, the presence of a cell wall-targeting anti-
biotic increased bacterial susceptibility to LL-37 as well as that of daptomycin. These observations suggest direct 
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interactions of the LL-37 molecules with charged components of the bacterial envelope in Gram-negative as 
well as in Gram-positive.
Figure 3.  Conductivity determination of LL-37 in planar lipid membranes. (A) No-peptide control. This trace 
was recorded before any addition of peptide. (B) Recording of LL-37 channel activity in planar lipid bilayers at 
200 mM KCl, 10 mM HEPES, pH 7 inside and 4 outside. The channel characteristics were recorded for several 
seconds and demonstrate the rapid conductivity fluctuations of the channel in lipid membranes. The scale bar (5 
pA) below the conductivity trace indicates the height of conductivity events. (C) Zoom in of the section marked 
with a red box in the channel recording of (A) depicted in another time scale indicates the fast conductance 
events in a 100 ms range (see scale bar). The current profile indicates three recurring conductivities termed 
O1, O2 and O3. (D) Channel conductances shown in (B) are quantified and current events (counts) were 
plotted against the current values in picoamperes (pA). This graph shows O2 to be the major conductance state 
with 13 pA, while additional O1 and O3 are recognized. (E) Current versus voltage graph for LL-37 at − 200 
to + 200 mV. The linear progression of conductivity with increasing voltage from − 200 to + 200 mV shows an 
ohmic behavior of the channel in planar lipid membranes.
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Characterization of the LL‑37 cell wall targeting mechanism in E. coli using cryo electron 
microscopy. In order to elucidate the mechanism of membrane disruption by LL-37 in vivo, E. coli cells were 
incubated with different peptide concentrations at different incubation times. First, we tested the cell wall altera-
tion effects at 5 and 25 μM peptide concentrations (below/near the MIC and above MIC, respectively) for one 
hour and observed that significant changes were only visible at 25 μM (see Fig. 5B). We therefore used this con-
centration for the following experiments and incubated the cells for 15, 60, 120 and 240 min (see Fig. 5A). In E. 
coli control cells the micrographs show the three distinct and undisturbed constitutive layers of the cell wall: the 
outer membrane, peptidoglycan and inner membrane (see Fig. S10A). The time-dependent disruption process 
of the cell wall after incubation with LL-37 is demonstrated in Fig. 5A. While the outer membrane remains intact 
after 15 min of treatment, perforation becomes apparent after 60 min together with membrane blebbing and the 
secretion of stress vesicles. After 120 min a significant deformation of both membranes is apparent but no strong 
perforation of the inner membrane and the peptidoglycan can be recognized. Progressing cell death is further 
highlighted by changes in the contrast of the cytoplasmic space molecules after four hours and the formation of 
discontinuities in the inner and outer membrane, deformation of membranes and the peptidoglycan essentially 
disappeared. Images of cells incubated with LL-37 at 25 μM for 16 h show the presence of empty membrane 
envelopes after damage of both membranes and the entire release of cytoplasmic constituents (see Fig. S10B).
In order to study if the morphological changes in E. coli after LL-37 incubation are unique or share common 
features with related AMPs we tested Dermcidin and SMAP under the same conditions at the same concentra-
tions. Dermcidin is unique in the negative net charge of -2 while SMAP has a strongly positive net charge of + 9, 
more similar to LL-37. E.coli cells were incubated for 1 h with 25 μM Dermcidin showing significant changes in 
the inner membrane while the outer membrane and the peptidoglycane remained essentially unchanged (see 
Fig. S11). For SMAP-29 we demonstrate that the outer membrane and the peptidoglycan are clearly visible after 
incubation of 1 h at 25 μM while the inner membrane shows deformations and changes in the morphology similar 
to Dermcidin (see Fig. S11). Collectively, these in vivo data of LL-37 indicate that the peptide perforates both 
membranes of E. coli cells in a time-dependent manner and this mechanism is clearly different to the mechanism 
employed by Dermcidin and SMAP.
Discussion
Antimicrobial peptides are considered to be one class of molecules used as the basis for the development of novel 
antibiotics. In spite of their co-evolution with bacteria, they retained activity against many multidrug resistant 
bacterial  strains2. One member of this class, the human cathelicidin LL-37 is probably the best studied antimicro-
bial peptide with a high activity against Gram-positive and -negative bacteria, including multi-resistant bacterial 
 strains10,52–54. The success of LL-37 at killing is based on high physiological concentrations of the full length and 
a set of proteolytically truncated peptides and the ability to target various bacterial cell envelope  molecules55,56. 
In a multistep mechanism, interactions with LPS, the peptidoglycan, the inner membrane and cytoplasmic 
proteins and DNA have been described, ultimately leading to cell  death56–60. In contrast to the specific targets 
Figure 4.  Molecular dynamics studies model the channel behaviour in membranes. (A) System setup used 
in the MD simulations. The LL-37 channel (orange and deep blue helices) embedded in a POPE/POPG (3:1) 
bilayer membrane (yellow and cyan) and a 1 M KCl salt solution  (K+: cyan spheres,  Cl−: brown spheres). For 
clarity the front part of the lipids has been omitted in the figure. (B) Side view of the comparison between 
the crystal structure and the average structure calculated from the MD trajectories. The crystal structure 
conformation is shown in a transparent fashion. (C) Change in the orientation (measured using the tilt angle) 
of the LL-37 channel during the simulations in POPE/POPG bilayer and their respective snapshots. (D) Water 
distribution (red/white spheres) in the LL-37 channel in the lipid bilayer (gray stick representation). (E) Average 
number of water molecules in bins of 2 Å width inside the channel averaged over the last 100 ns trajectory 
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of traditional antibiotics, LL-37 interacts with essential cellular structures, disturbing their proper function and 
evading bacterial resistance  mechanisms12,34,61,62. Understanding the targeting steps in structural detail would 
allow us to design LL-37 variants with increased efficiency for clinical applications. Therefore, we previously 
determined structures of LL-37 in complex with lipid-like molecules to understand the membrane-interacting 
mechanisms and showed the formation of peptide-detergent complexes as the basis for interactions with lipids 
followed by the formation of fibers (see Fig. 6)24,35. So far the structures of LL-37 showed monomers, dimers (in 
the presence and absence of detergents) and polymeric fibrils (shown by crystallography and electron micros-
copy). Fibril structures were formed only on the basis of LL-37/detergent- or LL-37/lipid-interactions followed 
by structural reorganization of termini and  polymerization24. The formation of fibril structures are common 
features of various peptides with antimicrobial activity including phenol-soluble modulins (PSMs), BTD-2, the 
cationic peptide LAH4 and amyloid peptides (beta amyloid (Aβ) and IAPP)25–28,63,64. Peptides such as Aβ, IAPP 
or LL-37 are conformationally flexible and form lower oligomeric states which may translate into fibers due 
to external  stimuli23,26,65,66. The mechanisms of fiber formation and their supramolecular organization depend 
on the peptide structure and plasticity. Oligomerization of amyloid peptides follows a pleiotropic spectrum of 
mechanisms but primarily includes β-fibrils of peptides in β-sheet conformation which assemble primarily via 
backbone  interactions67. By contrast for the ɑ-helical PSMs and LL-37 peptides fibril formation is guided mainly 
through side chain interactions and can be induced by detergents and lipids in the case of LL-3724,26. The function 
of these fibrils for amyloids is largely unknown but it was speculated that their formation in LL-37 may locally 
increase their concentration as a step prior to membrane insertion and a protective “armor” function against 
bacterial attack was also  proposed23. PSM fibrils are formed outside of cells and may serve to stabilize biofilms in 
S. aureus  cultures66; however, more work is needed to find out if the fibrils discovered under in vitro conditions 
also form in the same way in vivo.
In this paper, we report complementary experiments to understand interactions between LL-37 and the cyto-
plasmic bacterial membrane in more detail. We used membrane-mimicking detergents and lipids and studied 
complexes with wildtype and LL-37 mutants using structural biology, biochemistry and molecular dynamics. 
Broad studies of this type in the field of antimicrobial peptides in general and LL-37 in particular are still rare 
but they are of great importance for the understanding of AMP mechanisms and their structure-based design.
First we used lipids and detergents to generate LL-37 complexes reflecting membrane-associated states and 
studied peptide-detergent crystals by crystallography. Initially, to optimize the concentration of detergent for 
crystallization we determined secondary structure changes using circular dichroism along with increasing DPC 
concentrations and selected a DPC concentration of 1% which clearly increased the content of ɑ-helix (see 
Fig. S4). Under these conditions we obtained crystals of an asymmetric tetrameric peptide channel formed by two 
Figure 5.  Cryo-EM images of E. coli in the presence of LL-37 show membrane disruption. (A) Electron 
micrographs of E. coli treated with LL-37 after 15, 60, 120 and 240 min. The images show the disruption of the E. 
coli membrane after incubation. In untreated cells (See Fig. S10A) the cell wall shows a distinct pattern of outer 
membrane, peptidoglycan and inner membrane. While the outer membrane was almost undisturbed after short 
time exposition, additional discontinuities (see black triangles) appear after longer incubation subsequently 
leading to the disruption of the inner membrane and the formation of extracellular stress vesicles (see arrows). 
(B) The effect of LL-37 is concentration dependent. At concentrations beyond or around the MIC (5 µM) the 
cells maintain their shape and the cell wall is undisturbed while at concentrations clearly above the MIC (25 µM) 
fragmentation patterns are rapidly visible.
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identical dimers. We analyzed these dimers with respect to the previously published structures and found that 
the structure cannot be superimposed on LL-37 nor LL-37DPC-2, respectively as dimers. However, the monomer 
structures can be superimposed with a lower r.m.s.d for the membrane-associated states (LL-37DPC-4/LL-37DPC-2 
compared to LL-37DPC-4/LL-37) and both of these structures showed a partial disorder of the N-terminus in 
comparison to the detergent-free structure. LL-37 was also previously studied by NMR and here the peptide (in 
1% SDS) shows a monomeric and bent structure which significantly deviates from the crystal  structures44. The 
r.m.s.d. between the NMR structure and LL-37 is 2.6 Å (for 26 aligned CA positions), 2.4 Å to LL-37DPC-2 (27 
aligned CA positions) and 2 Å to LL-37DPC-4 (26 CA positions aligned). In another NMR study a helix-break-helix 
model of LL-37 in 1% DPC was determined which is reminiscent of the LL-37DPC-2  conformation45. This NMR 
study also confirmed the flexibility of N- (residues 1–12) and C-terminus (33–37) in the presence of detergents 
and proposed a random coil structured termini rather than an α-helical structure. This agrees with the significant 
structural rearrangement visible in our X-ray structures of LL-37DPC-4 and LL-37DPC-2 after detergent exposure 
with DPC (see Figs. 1, S1, S2, S3). All crystallographic structures of LL-37 show two antiparallel helices, an 
arrangement which resembles the previously published crystal structures of DCD, magainin-2 and melittin 
(Mel)35,68,69 (see Fig. S12A). The primary interfaces are stabilized by hydrophobic residues and form elongated 
structures of 4 (LL-37DPC-4), 3.5 (Mag-2M) and 8 nm (DCD), a length sufficient to span biological membranes 
(see Fig. S12B). Oligomer interfaces at high resolution have been discovered only for the hexameric dermcidin 
channel and in this work, showing alternating hydrophobic (IF1) and hydrophilic interfaces (IF2 and IF3) in 
LL-37DPC-4 (see Fig. S12C). While the LL-37DPC-2 structure is indicative for the carpet-like model, the observa-
tion of a tetrameric channel structure in LL-37DPC-4 suggests the barrel stave model as another putatively final 
step of membrane targeting (see Fig. 6E)35. Formation of such LL-37 channels may originate at membranes after 
dimerization and oligomerization and the peptide oligomers may be moved into membranes in response to 
transmembrane potentials as shown for Dermcidin, latarcins and Magainin-235,70,71. The targeting mechanisms 
are obviously complex and their description requires new models based on combinations of the enhanced scheme 
of Nguyen et al.30.
Could the tetrameric state of LL-37 resemble a possible conformation obtained in native membranes? We 
identified various structural features of LL-37DPC-4 underlining its potential to form similar channels in vivo: (I) 
the length of LL-37DPC-4 fits the biological membrane thickness (see Fig. 1, S1, S2); (II) the peptide interfaces 
show significant intermolecular interactions and follow an antiparallel orientation similar to the DCD channel, 
together with the alternating interfaces (see Figs. 1, S12); (III) the properties of the structure when integrated in 
membranes show minor unfavorable electrostatic violations with the membrane environment; (IV) two girdles 
formed by aromatic residues surround the periphery of the channel center at a distance of ~ 2 nm (see Fig. 1B). 
Such girdles, together with positively charged flanking residues, have frequently been observed in inner and 
outer membrane protein structures and appear to stabilize membrane proteins by the formation of protein-lipid 
 contacts72,73.
To experimentally prove that the channel could also form under physiological conditions, additional experi-
ments were conducted which demonstrate oligomerization as a prerequisite step towards channel formation: 
Figure 6.  Proposed model of LL-37 interactions with the bacterial cell wall. A final killing step has been added 
to the previous proposed model of LL-37 interactions with the bacterial cell  wall24. After initial electrostatic 
attraction with the outer membrane via LL-37/LPS or LL-37/LTA complexes (A), LL-37 interacts with the PE of 
the inner membrane (B) and lipids may be extracted from the membrane (C) with the consequent formation of 
the activated peptide conformation LL-37 LDAO-2 (D). (E) The final killing step of LL-37 follows by integration of 
the peptide into membranes as conducting channels, leading to the breakdown of the transmembrane potential.
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(A) based on cross-linking, size exclusion chromatography and analytical ultracentrifugation in the presence 
of detergents higher molecular oligomers could be  demonstrated24,74. Cross-linking of LL-37 in the presence of 
detergents and lipids showed the formation of higher-molecular oligomers, although not only tetramers but also 
higher oligomeric states. In particular negatively charged lipids and detergents seem to interact more strongly 
with the peptide and also induce changes in the secondary structure (see Fig. 2); (B) according to the LL-37DPC-4 
structure, a small conductivity was expected and planar lipid membrane measurements confirmed 13 pS in 
200 mM KCl (65 pS in 1 M salt) which is in the range of the channel conductance in the range of the 81 pS (at 
1 M KCl) for the hexameric DCD  channel35; (C) finally, MD simulations in membranes proved channel structural 
stability within the time frame tested, and a similar tilting angle in membranes as previously determined for DCD 
was  reached35. We are aware that the diameter of the channel, together with the MD results may imply that no 
ion permeation is possible. The channel is, e.g., clearly too narrow for the translocation of hexaquo-sodium or 
potassium ions; however it is also known for tetrameric ion channels (with a conductivity of 0.1–100 pS), that 
ions move along backbone carbonyl atoms through these narrow channels in the absence of a hydration shell 
and hence, it seems plausible that also LL-37 could act by a similar  mechanism75 while the present simulation 
time might be too short to capture such events. (D) To test lipid affinities of LL-37 we used MD simulations of 
LL-37 in POPE/POPG (as prototypes for bacterial membranes) and POPC (mimicking mammalian membranes) 
membranes and verified those simulations experimentally by circular dichroism analysis. POPG and POPC have 
a zero spontaneous curvature but POPG has a negative charge while POPC is neutral at physiological  pH76. POPE 
is formally uncharged but according to experimental data in nanodiscs is negatively charged at pH 7.477. In our 
MD simulations of the LL-37 tetramer the number of hydrogen bonds with POPE/POPG lipid membranes was 
clearly greater than with a POPC. This difference in affinity was also observed in earlier MD simulation using 
LL-37 as a monomeric peptide showing a higher stability in POPG rather than  POPC78. To experimentally verify 
this calculated stability difference of LL-37 (from MD) in the same lipid systems used for MD we applied LL-37 to 
mixtures of PE/PG and PC at different ratios. While the folding propensity along with the increase in secondary 
structure was higher for the negatively charged PE/PG vesicles in particular for ratios of peptide/lipid (1:10—see 
Fig. 2) the presence of the uncharged PC vesicles at all ratios decreased the intensity of the a-helical signal. The 
differential binding of LL-37 to lipids of different charges (PG/PE relative to PC) has previously also been shown 
by Sood et al. and highlights the biologically important function of LL-37 to discriminate target versus host cell 
 membranes79. Previously we have used the DPC detergent carrying the same head group as PC for crystallization 
and circular dichroism. Interestingly, in contrast to PC the spectra showed a clear increase in secondary structure 
consequently folding propensity upon increased detergent concentrations. This effect could possibly be due to 
the physical structure of a micelle relative to a vesicle in diameter and shape (detergent micelle strongly bent 
relative to a vesicle)79. Taken all data together, we can provide biochemical data (raised under points A–D) which 
are in support of the LL-37 assembling into the LL-37DPC-4-like structure tested under different conditions (lipid 
membranes, pH, salt) thereby suggesting that the channel formation under ‘crystallization conditions’ may also 
occur in artificial or biological membranes.
Interactions between antimicrobial peptides and the bacterial cell envelope at higher resolution using cry-
oelectron microscopy are rare. When we started our investigation we imagined that the peptide would cross the 
outer membrane via outer membrane channels and used mutants of the Keio collection to test this  hypothesis80. 
We used 20 knockout mutants of porins and proteins of the Ton and Tol complex but we did not obtain evident 
results. Next we tested the interactions of LL-37 with the bacterial cells in an in vivo setup. Using high resolution 
cryoelectron microscopy, images were recorded, clearly showing the three different layers of the cell wall; the 
outer membrane, the peptidoglycan and the inner membrane. Based on the resolution acquired for wildtype cells 
we were hoping to be able to specifically investigate the individual influence of LL-37 on these substructures and 
to link the activity to interactions studies with LPS, LTA and lipids. Wildtype E. coli cells were treated with LL-37 
and the peptides SMAP-29 and DCD to compare if similar morphological changes would appear. The effects of 
LL-37 on the cell wall are time and concentration dependent, and clear discontinuities in the outer membrane 
develop after 120 min and cells start to become leaky with clear gaps in both membranes allowing for the release 
of cytosolic compounds. In contrast, the mechanism by which DCD acts on the same cell type yields different 
morphological changes (see Fig. S11). DCD is a unique peptide due to its charge properties (surplus of negative 
charges) and should only weakly interact with the negatively charged LPS or LTA molecules,  respectively81. This 
unique property is reflected by the fact that the outer membrane remains intact while the inner membrane shows 
strong deformation and breaks. SMAP-29, although even more strongly positively charged than LL-37, shows a 
similar influence on the bacterial cell wall to DCD, acting primarily on the inner membrane but leaving the outer 
membrane and the peptidoglycan layer largely intact. Membrane deformations also occur here at a very early 
time points, however the outer membrane remains intact while the inner membrane collapses and fragmenta-
tion is visible. In other experiments where E. coli cells were exposed to LL-37 and other cathelicidins the authors 
found stress vesicles also observed in our studies and wrinkles after an earlier time point of  incubation82,83. These 
observations were concentration dependent but occurred already at concentrations below the MIC and strong 
damage of the cell was observed at concentrations above the MIC and the overall killing time of E. coli was faster 
typically within  minutes82.
One of the major aims of this work was also to find a better model describing interactions between the antimi-
crobial peptide LL-37 and bacterial cells focusing on the bacterial cell wall. Based on previous and unpublished 
studies we propose a mechanistic model which highlights LL-37 interactions with LPS and LTA as the first step 
of targeting. These interactions at the bacterial surface lead to the extraction of LPS to form holes in the outer 
membrane. Higher oligomerization state and fiber formation may be the next step induced by interactions with 
the cytoplasmic membrane. These fibers may be necessary to increase the local peptide concentration and to 
locally extract lipids from the cytoplasmic membrane after peptide interactions. A transmembrane potential 
may be necessary to pull the channel into the membrane (e.g. in case of DCD). The channel formation leads to 
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the breakdown of the transmembrane potential and ultimately cell death (see Fig. 6). As the formation of the 
tetrameric pore would require a biological membrane together with ion transmembrane gradients, we assume 
that this channel would be stable only in the context of the inner membrane. Therefore, we cannot postulate the 
tetramer as a general oligomeric form of LL-37 in every context or lipidic membranes rather as one of several 
possible snapshots of LL-37 structures. In summary: In this and a previous paper on LL-37 we showed signifi-
cant structural variability exhibited by LL-37 and we suspect that they are only a subset of other physiologically 
important conformations. This structural flexibility might allow LL-37 to adapt and interact with LPS and and 
also the outer or inner membranes, respectively, which is a prerequisite for the various activities of the peptide.
Summary
This work shows new peptide-peptide and peptide-detergent interaction sites of LL-37 deciphered at atomic 
resolution, together with various modes of oligomerization. We show for the first time the unusual structural 
plasticity of this peptide towards several cellular target molecules shown by four crystal structures. Structural 
work leading to the identification of residue specific interactions in these complexes can be used for the design 
of novel LL-37 peptides with e.g. increased stability of dimer interfaces, hence improved activity. Interactions 
of the four different structures are assembled in Fig. S3 and residues primarily involved in these interactions 
are located in the peptide center from Lys12 to Phe27. So far, point mutants E16A and R23A and their altered 
activity indicate the correctness of the structures and the potential to change the activity based on single muta-
tions, also in the context of cellular targets. Terminal deletion mutants LL-27 and FR-22 were inactive in killing 
bacteria but could be activated by adding detergents which opens another venue for the development of new 
peptide antibiotics based on structural information. These detergents seem to stabilize certain portions of the 
dimer interface and enhance the ability for oligomerization and enhance the antimicrobial activity. The different 
peptide-peptide and peptide-detergent interactions are displayed in Fig. S13, and they indicate that the central 
part of the sequence is the most important for structure maintenance. Deletion mutants created based on this 
information, and truncated peptides from the literature, prove the importance of these  residues24. However, 
important structural information regarding the complexes between LL-37 and LTA or LPS is still missing and 
they would add on another important piece of knowledge. Future studies can build on this information to create 
smaller LL-37 variants with similar activity which may be further introduced in preclinical and clinical studies.
Materials and methods
Peptides, lipids and detergents. All peptides used in our study were chemically synthesized and pur-
chased from Peptide2.0 (www.pepti de20.com) at purities higher than 95%. DPC was purchased from Affy-
metrix, while cholesterol and 3-sn-phosphatidylethanolamine (PE) were purchased from Sigma-Aldrich. 
1,2-diphytanoyl-sn-glycero-3-phosphocholine (DPhPC) and phosphatidylglycerol (PG), dissolved in chloro-
form were purchased from Avanti Polar Lipids. Phosphatidylcholine (PC) from soybeans was acquired from the 
List of European Pharmacopoeia Reference Standards (EDQM).
Crystallization and crystallographic studies of LL‑37. Crystallization of the tetrameric channel was 
conducted with peptide-detergent mixtures (20 mg/ml LL-37, 0.5% DPC) in a 2 mM sodium phosphate pH 6.8 
buffer, using the commercial screens from Jena Bioscience, Qiagen and Molecular Dimensions. Sitting drops of 
400 + 400 nl (peptide + reservoir) were prepared by a Mosquito robot (TTP Labtech) and the progress of crystal 
formation was monitored using the Formulatrix Rock imaging system. Crystals were mounted from crystalliza-
tion drops and data were collected at the synchrotron source SLS (Swiss Light Source, Villigen, Switzerland—
beamline PX10). Data were recorded on the Pilatus detector 6 M (Dectris) at 100 K with beam attenuation of 
20–50% at beamline PX10. Data were processed using the XDS/XSCALE program  package84. The high resolu-
tion structure of monomeric LL-37 crystallized in  DPC24 was employed as a search model to solve the tetrameric 
structure obtained in the presence of DPC. The structure was refined by  Refmac85,  Phenix86 and  BUSTER87 and 
manually modelled using the COOT program  package88. Based on  FO-FC difference maps, detergent molecules 
were added and refined together with the peptide model. The geometry of the structure was validated using the 
Molprobity server (https ://molpr obity .bioch em.duke.edu/). All refinement and model statistics are given in table 
SII.
Vesicle preparation. The phospholipid vesicles were prepared by pipetting the lipids (chloroform resus-
pended) in borosilicate-glass culture tubes with teflon-lined screw caps. The organic solvent was removed by 
evaporation under a nitrogen stream by using a dry heated nitrogen evaporator. The dried lipids were hydrated 
by adding 5 mM phosphate buffer pH7, 0.1 M NaCl with the consequent obtaining of multilamellar vesicles 
(MLV). Small unilamellar vesicles (SUV) were obtained by vortexing and sonication in the bath sonicator for 
15 min at room  temperature89. After sonication, the peptide was added to the SUVs at the indicated ratio and 
incubated at room temperature for 5 min before CD and cross-linking performance.
Characterization of peptides by circular dichroism (CD). 40 μM (CD with PE:PG or PC) in 100 mM 
NaCl, 5 mM phosphate, pH 7, was used for the secondary structure determination using a CD JASCO J-815 
spectrophotometer (Jasco Spectroscopic Co. Ltd., Hachioji City, Japan). Peptides were analyzed at 20 °C and a 
scanning speed of 100 nm/min with a band width of 1 nm. All spectra were recorded at 0.5 nm resolution and 
data were reported as differences in molar absorption. The samples were measured in quartz precision cuvettes 
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Cross‑linking experiments. LL-37 at a concentration of 40 μM (with lipids) was subjected to cross-linking 
using the amino-reactive cross-linker BS3 (Thermo Scientific, Pierce Biotechnology, Inc.). BS3 at a final concen-
tration of 1 mM was added to the samples used previously for the CD and the incubation was continued for 1 h 
at 37 °C while shaking. The reaction was stopped by addition of 50 mM Tris–HCl, pH 8 and the mixture was kept 
for 15 min at room temperature. The sample was mixed with a denaturing Laemmli buffer and boiled for 10 min 
at 95 degrees. Samples were loaded on Novex 10–20% tricine gels (Invitrogen Life Technologies) and analyzed 
after silver staining for the cross-linking done in the presence of lipids.
Electrophysiology measurements. Planar lipid bilayers were obtained from GUVs prepared by using 
electroformation method in an indium tin oxide (ITO) coated glass chamber connected to the Nanion Vesi-
cle Prep Pro setup (Nanion Technologies GmbH, Munich, Germany)90. Lipid-containing solution, 10 mM of 
1,2-diphytanoyl-sn-glycero-3-phosphocholine (DPhPC) with 10% cholesterol, dissolved in chloroform, was 
deposited on the ITO-coated glass surface. After total evaporation of the solvent the lipids were assembled in a 
perfectly dehydrated lamellate phase. 300 μl of a non-ionic intracellular solution, sorbitol (1 M) was added to the 
dry lipid film. The process of electroformation was controlled by the Vesicle Prep Pro instrument and all param-
eters (amplitude, frequency, duration, etc.) for the electroformation were programmed in the VesicleControl 
software (Nanion Technologies GmbH, Munich, Germany). Generally, an alternating voltage of 3 V peak to peak 
was applied with a progressive increase for the rise time and a decrease for the fall time to avoid abrupt changes, 
which otherwise might rupture the formed GUVs. The frequency of the alternating current was 5 Hz and was 
applied to the ITO-slides over a period of 2 h at room temperature. After successful swelling, the vesicles were 
used directly for the planar lipid bilayers formation. For the formation of the planar lipid bilayer, the GUVs were 
positioned onto the aperture of the Port-a-Patch automated patch clamp system (Nanion Technologies GmbH, 
Munich, Germany), using borosilicate glass chips with an aperture diameter of approximately 1 μm. Typically, 
(−)10 to (−)40 mbars were sufficient for reliable positioning within a few seconds after GUV addition. When 
the GUVs touch the glass surface of the chip, they burst and form planar  bilayers91. LL-37 was reconstituted by 
simple addition to the top of the chip where the bilayers were sitting. After a period of incubation we started to 
see activity that mainly conducted to the breaking of the membrane when used at the purification concentration 
directly. After several dilutions, single channel activity could be observed. The recordings were done at a trans-
membrane potential of + 100 mV with 200 mM KCl, 10 mM HEPES at pH 7 inside and pH 4 outside.
Molecular dynamics simulations. All molecular dynamics (MD) simulations were performed using the 
CHARMM36 force  field92,93 and the GROMACS 4.6.5  software94. Short-range pairwise electrostatic interac-
tions were considered up to 1.2  nm and beyond it calculated with the particle-mesh Ewald  method95. Fur-
thermore, van der Waals (VdW) interactions were considered up to a distance of 1 nm which smoothly turn 
off at 1.2 nm. As a starting structure for the MD simulation setup, the crystal structure of the LL-37 tetramer 
was inserted into a heterogenous bilayer built of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylethanolamine 
and 1-palmitoyl-2-oleoyl-sn-glycero-3-phospo-(1′-rac-glycerol) (POPE and POPG) lipids at a ratio of 3:1 gen-
erated using CHARMM-GUI Membrane  Builder96,97. This negatively charged bilayer composed of POPE and 
POPG lipids should yield a reasonable model for bacterial inner  membranes98. The bilayer was aligned parallel 
to the xy plane and centered in the z direction. In a subsequent step, the lipid bilayer together with the LL-37 
channel was solvated in a periodic TIP3P water box with 1 M KCl resulting in a system size of approximately 
80 Å × 80 Å × 100 Å (see Fig. 4A). A similar procedure was used for setting and equilibrating the homogenous 
POPC, POPE and POPG bilayer systems with LL37 embedded in the respective membrane and a 1 M KCl solu-
tion. All four systems were equilibrated using the well-established protocol developed in the CHARMM-GUI 
Membrane Builder and followed by two 200 ns production runs for each setup in a constant temperature and 
pressure (NPT) ensemble achieved by a Nóse-Hoover  thermostat99,100 with a coupling constant of 1 ps and a 
semi-isotropic Parrinello-Rahman  barostat101 at 1 bar with a coupling constant of 5.0 ps. An integration time 
step of 2  fs was used by constraining the hydrogen bonded atoms to their equilibrium lengths with LINCS 
 algorithm102. The tilt angle is defined as the cosine of the angle between two vectors, i.e., principal axis of the 
starting structure and the respective frames in the trajectory. Hydrogen bonds were calculated using the g_
hbond tool based on the geometric criteria for the distance between donor–acceptor being less than or equal to 
0.35 nm and the angle between hydrogen-donor–acceptor being less than or equal to 30°.
Microbial assays of LL‑37 peptide. Potential synergistic effects of LL-37 and antimicrobial agents were 
evaluated on a solid medium (Muller Hinton agar plate). Etest strips (bioMérieux, La Balme, France) with antibi-
otics from three distinct families targeting cell wall components (ceftobiprole, tigecycline) or lipid metabolisms 
(daptomycin), were performed on Muller Hinton agar plates containing LL-37 at a concentration of 25 mg/l 
compared to the same medium free of LL-37. Solid medium (20 ml) was kept at 45 degrees and enriched with 
LL-37 at indicated concentration under constant supervision. Plates were then incubated at ambient tempera-
ture until solidification. The inoculum suspension was prepared from overnight cultures at a standardized titer 
of 0.5 McFarland and inoculated with a cotton swab over the entire surface of the Mueller–Hinton agar plate 
by swabbing in three directions. Etest containing indicated antibiotics were added onto the agar surface before 
incubation for 16 h at 37 °C. Three independent replicates were performed and showed the same result.
Preparation of bacterial cells treated with AMPs for cryo‑EM and data collection. Escherichia 
coli K12 cells were grown at 37 °C at 200 rpm to an  OD600 of 0.6. LL-37, SMAP-29 and Dermcidin were added to 
1 ml cultures to reach a final concentration of 5 µM (23 µg/ml) or 25 µM (115 µg/ml), depending on the experi-
ments, and cultures were further incubated at 37 °C while shaking at 300 rpm (Eppendorf Thermomixer, Ham-
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burg, Germany). After increasing times (15, 60, 120, 240 min and overnight) 100 μl of the samples or controls 
without AMPs were taken and cells were pelleted at 3000*g for 10 min at 4 °C. The cell pellets were resuspended 
using 20 μl of culture solution in order to concentrate the sample and reach a sufficiently high cell density for the 
visualization in the microscope.
To prepare vitrified grids for cryo-EM experiments, 4 µl of the concentrated sample solution in the case of 
the experiments with E. coli cells or from the vesicles incubated with LL-37 or LL-37 labeled with nanogold 
were applied onto glow-discharged Quantifoil R 2/1 200-mesh holey-carbon grids. Later the grids were blotted 
with a paper filter and were abruptly plunged in a liquid ethane bath, cooled with liquid nitrogen to − 196 °C, 
using a Vitrobot (FEI). Vitrified grids were cryo-transferred into a 626 DH cryo transfer holder (Gatan Inc.) and 
manually analyzed on a JEM-2200FS/CR (JEOL, Ltd.) transmission electron microscope equipped with a field 
emission gun (FEG) operated at 200 kV. No-tilted zero-loss two-dimensional (2D) images were collected under 
low-dose conditions, with a total dose of the order of 10–20 electrons/Å2 per exposure, on a 4 K × 4 K 15 µm pixel 
Ultrascan4000™ CCD camera (Gatan Inc.), at defocus values ranging from 2.0 to 4 µm. The in-column Omega 
energy filter of the microscope helped to record images with improved signal-to-noise (SNR) ratio by zero-loss 
filtering, using an energy slit width of 15 eV centered at the zero-loss peak of the energy spectra. Digital images 
were recorded using DigitalMicrograph™ (Gatan Inc.) software at different nominal magnifications, between 
30,000 × and 60,000 ×, resulting in a final pixel size between 3.6 Å/pixel and 1.7 Å/pixel respectively.
Data availability
The structure of LL-37DPC-4 has been deposited at the PDB database under the following number: 5G1J.
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